TE_12
Basic information Differential Expression Stage analysis Survival analysis Correlation analysis| TE family | L1M4b_5end |
|---|---|
| TE superfamily | L1 |
| TE class | LINE |
| Gene | - |
| Class | Intergenic |
| Coding | Non-coding |
| Tumor-specific score | 0.29 |
| Counts of samples | TCGA_tumor:830; TCGA_normal:54; GTEx:3228 |
| TSS | chr1(-):839676 |
Transcript isoforms
| Transcript_ID | Gene | Class | Coding | ORF | Position |
|---|---|---|---|---|---|
| teRNA_12.1 | - | Intergenic | Non-coding | Non-coding | chr1(-):839298,839318,839361,839444,839557,839677 |
| teRNA_12.2 | - | Intergenic | Non-coding | Non-coding | chr1(-):839326,839346,839375,839444,839557,839677 |
| teRNA_12.3 | - | Intergenic | Non-coding | Non-coding | chr1(-):839298,839318,839417,839528,839557,839677 |
| teRNA_12.4 | - | Intergenic | Non-coding | Non-coding | chr1(-):839298,839318,839361,839444,839501,839528,839557,839677 |
| teRNA_12.5 | - | Intergenic | Non-coding | Non-coding | chr1(-):839298,839318,839361,839528,839557,839677 |
| teRNA_12.6 | - | Intergenic | Non-coding | Non-coding | chr1(-):839326,839346,839445,839528,839557,839677 |
| teRNA_12.7 | - | Intergenic | Non-coding | Non-coding | chr1(-):839326,839346,839375,839528,839557,839677 |
| teRNA_12.8 | - | Intergenic | Non-coding | Non-coding | chr1(-):839284,839304,839445,839528,839557,839677 |
| teRNA_12.9 | - | Intergenic | Non-coding | Non-coding | chr1(-):839298,839318,839361,839486,839571,839677 |
| teRNA_12.10 | - | Intergenic | Non-coding | Non-coding | chr1(-):839326,839346,839375,839486,839571,839677 |
1
2
GTEx
The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.
TCGA
The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).
GTEx
The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.
